Recent Quotes (30 days)

You have no recent quotes
chg | %

Taxus Cardium Pharmaceuticals Group Inc  

(Public, OTCMKTS:CRXM)   Watch this stock  
Find more results for AMEX:CXM
0.194
-0.001 (-0.31%)
Apr 1 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.17 - 0.19
52 week 0.07 - 0.78
Open 0.17
Vol / Avg. 17,183.00/12,428.00
Mkt cap 2.39M
P/E     -
Div/yield     -
EPS -0.53
Shares 12.31M
Beta 2.79
Inst. own 10%
Jun 5, 2015
Taxus Cardium Pharmaceuticals Group Inc Annual Shareholders Meeting (Estimated) - 12:00PM EDT - Add to calendar
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -6324.91%
Operating margin - -6324.40%
EBITD margin - -6052.93%
Return on average assets -214.84% -130.38%
Return on average equity -1527.32% -193.69%
Employees 11 -
CDP Score - -

Address

11750 Sorrento Valley Rd Ste 250
SAN DIEGO, CA 92121-1061
United States - Map
+1-858-4361000 (Phone)
+1-858-4361001 (Fax)

Website links

Description

Taxus Cardium Pharmaceuticals Group Inc., formerly Cardium Therapeutics, Inc., is a development-stage regenerative medicine biotechnology company. The Company is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs. The Company�s products include Generx and Excellagen. Generx, Cardium�s lead Phase III clinical study product candidate, is a transformative disease-modifying angiogenic gene therapy growth factor therapeutic that is being developed for the treatment of Cardiac Microvascular Insufficiency (CMI). Excellagen is Aseptic Pharmaceutically-Formulated Fibrillar Collagen developed based on technology through its acquisition of the Tissue Repair Company .The Company�s wholly owned subsidiaries include Tissue Repair Company, To Go Brands, Inc. and LifeAgain Insurance Solutions, Inc., an advanced medical data analytics business.

Officers and directors

Christopher J. Reinhard Chairman of the Board, President, Chief Executive Officer, Treasurer
Age: 60
Dennis M. Mulroy CPA Chief Financial Officer
Age: 59
Gabor M. Rubanyi M.D., Ph.D. Chief Scientific Officer
Age: 67
Tyler M. Dylan-Hyde J.D., Ph.D. Director
Age: 52
John Wallace Director
Jiayue Zhang Director
Age: 54
Wei-Wei Zhang Ph.D., M.D. Director
Age: 57
Edward W. Gabrielson M.D. Independent Director
Age: 61